StockMarketWire.com - Tiziana Life Sciences, a clinical stage biotechnology company developing targeted drugs for cancer and autoimmune diseases, has raised £825,000 in cash by the issue of 1,031,250 new ordinary shares at a price of 80p per share.
In addition, the company has issued 51,563 new ordinary shares credited as fully paid and 51,563 warrants exercisable at a price of 80p per share to intermediaries in lieu of commissions on the funds raised.
The company has undertaken a number of smaller fund raises over past year to provide it with its working capital requirement. As the company is at pre-revenue stage and engaged in research and development, it is reliant on raising further funds in the equity markets to provide it with its ongoing working capital requirement.
At 8:05am: [LON:TILS] Tiziana Life Sciences Plc share price was -0.25p at 81.75p
Story provided by StockMarketWire.com
Shares Magazine
Shares is the leading weekly publication for retail investors. It is packed with investment ideas, news and educational material to help build and run portfolios and get more from your money.
Investor Events
Shares puts on free Investor Events throughout the year across the country. They provide an opportunity for investors to learn more about companies on the stock market and hear from a range of investment experts including fund managers and Shares journalists.